This week’s roundup features research reinforcing the need for better universal surveillance for developmental delays and increased access to early intervention. This and more In The News.
It has been a whirlwind week for most Americans, so if you need to break away from political news to catch up with your science news, you've come to the right place. This installment of In the News starts with an important study for patients with rare primary immunodeficiency diseases at risk of side effects from the rubella vaccine. Next,
A CHOP physician discovers a new drug that may change her patients' lives. "It's like the opposite of diabetes." That is the simplest way to explain congenital hyperinsulinism (HI), a rare disease in which the pancreas makes too much of the hormone insulin, causing blood glucose to plummet.
